SanBio announced that it recorded foreign exchange gains of 177 million yen and a corporate tax adjustment of 55 million yen in the first quarter of the fiscal year ending January 2027, impacting its performance.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4592","jir_company_name":"SanBio Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-06-15","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/4592-20260615-02.pdf","jir_short_summary":"SanBio announced that it recorded foreign exchange gains of 177 million yen and a corporate tax adjustment of 55 million yen in the first quarter of the fiscal year ending January 2027, impacting its performance.","jir_summary":"### Overview of Performance\nIn the first quarter from February 1 to April 30, 2026, SanBio recorded foreign exchange gains of 177 million yen due to fluctuations in the exchange rates. This was mainly caused by foreign currency-denominated loans and related receivables, along with a foreign exchange translation adjustment of -136 million yen. Additionally, the company recognized a corporate tax adjustment of 55 million yen due to the recognition of deferred tax liabilities related to foreign currency-denominated loans. These items have had a certain impact on the performance.\n\n### Future Outlook and Investor Impact\nThe foreign exchange gains and tax adjustments recognized this time are attributable to temporary exchange rate fluctuations, and their long-term impact on future performance remains uncertain. SanBio is actively reviewing its foreign exchange risk management and tax strategies, and attention should be paid to upcoming financial summaries and earnings guidance. Investors need to consider the impact of exchange rate fluctuations while evaluating the company\u2019s risk management and medium- to long-term business strategies.","jir_financial_highlights":"Non-Operating Income: 177 million yen (Increase due to foreign exchange gains)\nCorporate Tax Adjustment: 55 million yen (Recognized due to deferred tax liabilities related to foreign currency-denominated loans)","jir_category":"","jir_hashtags":"#SanBio, #FinancialResults, #JapaneseStocks","jir_key_figures":"Non-Operating Income: 177 million yen\nCorporate Tax Adjustment: 55 million yen\nPeriod: February 1 to April 30, 2026","jir_meta_title":"\u3010SanBio\u3011Q1 FY2026 Foreign Exchange Gains and Tax Adjustment\uff5cJune 15, 2026","jir_meta_description":"SanBio announced recording foreign exchange gains of 177 million yen and a corporate tax adjustment of 55 million yen in Q1 FY2026, impacting its performance. Detailed explanation provided.","jir_og_title":"\u3010SanBio\u3011Q1 FY2026 Foreign Exchange Gains and Tax Adjustment\uff5cJune 15, 2026","jir_og_description":"SanBio reported foreign exchange gains of 177 million yen and a corporate tax adjustment of 55 million yen in Q1 FY2026, influencing its financial results. Detailed explanation.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9416,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-64525","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n